ASIERIS PHARMACEUTICALS ENTERS AN EXCLUSIVE LICENSING AGREEMENT WITH THERAMEX FOR CEVIRA® SUBJECT TO CERTAIN CONDITIONS, ADVANCING THE GLOBAL DEVELOPMENT AND COMMERCIALIZATION OF A NON-SURGICAL TREATMENT FOR CERVICAL PRECANCEROUS LESIONS IN EUROPE

Reuters · 2d ago

Please log in to view news